Recombinant interferon beta gel as an adjuvant in the treatment of recurrent genital warts: Results of a placebo-controlled double-blind study in 120 patients

Dermatology

Volumn 196, Issue 3, 1998, Pages 330-334

  Gross, G ^a,e   Rogozinski, T ^b   Schofer H ^c   Jablonska S ^d   Roussaki, A ^a   Wohr C ^d   Brzoska, J ^d  

^a UNIVERSITY OF HAMBURG   (Germany)

^b UNIVERSITY OF WARSAW   (Poland)

^c GOETHE UNIVERSITY   (Germany)

^d Rentschler Biotechnology ^*  (Germany)

^e UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Adjuvant therapy; Condylomata acuminata; Genital warts; Human papillomavirus; Interferon gel; Topical preparations

Indexed keywords

RECOMBINANT GAMMA INTERFERON;

ADULT; ARTICLE; CAUTERIZATION; CLINICAL TRIAL; CONDYLOMA ACUMINATUM; CONTROLLED STUDY; CRYOSURGERY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FLU LIKE SYNDROME; HUMAN; LASER SURGERY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; RECURRENT DISEASE; SIDE EFFECT; TIME; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, CUTANEOUS; ADULT; ANTIVIRAL AGENTS; CHEMOTHERAPY, ADJUVANT; CONDYLOMATA ACUMINATA; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INTERFERON-BETA; MALE; PILOT PROJECTS; RECOMBINANT PROTEINS; RECURRENCE; SKIN DISEASES; TREATMENT OUTCOME;

EID: 0031976557     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000017906     Document Type: Article

References (25)

1. Nuovo GJ, Blanco JS, Leipzig S, Smith D: Human papillomavirus detection in cervical lesions nondiagnostic for cervical intraepithelial neoplasia: Correlation with Papanicolaou smear, colposcopy, and occurrence of cervical intraepithelial neoplasia. Obstet Gynecol 1990; 75:1006-1011.
2. MMWR: Condyloma acuminatum - United States, 1966-1981. Morb Motal Wkly Rep 1983;32:306-308.
3. Becker TM, Stone KM, Alexander ER: Genital human papillomavirus infection: A growing concern. Obstet Gynecol Clin North Am 1987; 14:389-396.
4. von Krogh G, Gross G, Barrasso R: Warts and HPV-related squamous cell tumors of the genitoanal area in adults; in Gross G, von Krogh G (eds): Human Papillomavirus Infections in Dermatovenereology. Boca Raton, CRC Press, 1997, pp 259-304.
5. Cobb MW: Human papillomavirus infection. J Am Acad Dermatol 1990;22:547-566.
6. Gross G, Jabłońska S, Pfister H, Stegner HE (eds): Genital Papillomavirus Infections. Modern Diagnosis and Treatment. Berlin, Springer, 1990.
7. Cirelli R, Tyring SK: Interferons in human papillomavirus infections. Antiviral Res 1994;24:191-204.
8. Stone KM: Human papillomavirus infection and genital warts: Update on epidemiology and treatment. Clin Infect Dis 1995;20(suppl 1): 91-97.
9. Editorial: Persistent anogenital warts. Lancet 1991;338:1114-1116.
10. Jensen SL: Comparison of podophyllin application with simple surgical excision in clearance and recurrence of perianal condylomata acuminata. Lancet 1985;ii:1146-1148.
11. Gross G: Interferons; in Eisner P, Eichmann A (eds): Sexually Transmitted Diseases: Advances in Diagnosis and Treatment. Curr Probl Dermatol. Basel, Karger, 1996, vol 24, pp 233-246.
12. Ferenczy A, Mitao M, Nagai N, Silverstein SJ, Crum CP: Latent papillomavirus and recurring genital warts. N Engl J Med 1985;313: 784-788.
13. Rockley PF, Tyring SK: Interferons alpha, beta and gamma therapy of anogenital human papillomavirus infections. Pharmacol Ther 1995; 65:265-287.
14. Brzoska J: Topische Interferonpräparationen bei dermatologischen Erkrankungen; in Gross, Bröcker EB (eds): Interferon-Therapie in der Dermatologie. München, Zuckschwert, 1994, pp 1-9.
15. Ikic D, Trajer D, Cupak K, Petricevic I, Prazic M, Loldo I, Jusic D, Smerdel S, Soos E: The clinical use of human leukocyte interferon in viral infections. Int J Clin Pharmacol Ther Toxicol 1981;19:498-505.
16. Syed TA, Lundin S, Cheema KM, Kahlon BMM, Cheema R, Ahmad SA, Ahmad M: Human leukocyte interferon-α in cream, for the treatment of genital warts in Asian women: A placebo-controlled, double-blind study. Clin Invest 1994;72:870-873.
17. Syed TA, Cheema KM, Khayyami M, Ahmad SA, Ahmad SH, Ahmad S, Ahmad SA: Human leukocyte interferon-alpha versus podophyllotoxin in cream for the treatment of genital warts in males. Dermatology 1995;191:129-132.
18. Syed TA, Khayyami M, Kriz D, Svanberg K, Kahlon RC, Ahmad SA, Ahmad SA: Management of genital warts in women with human leukocyte interferon-α vs. podophyllotoxin in cream: A placebo controlled, double-blind comparative study. J Mol Med 1995;73:255-258.
19. Keay S, Teng N, Eisenberg M, Story B, Selleres PW, Merigan TC: Topical interferon for treating condylomata acuminata in women. J Infect Dis 1988;158:934-939.
20. Brzoska J, Deutschle R, Fierlbeck G, Manske U, Wolf W: Phase II clinical trials of interferon beta gel (Fiblaferon® gel) in dermatological diseases. J Interferon Res 1989;9(suppl 2):259.
21. Gross G: Interferone bei Erkrankungen der Haut und der angrenzenden Schleimhäute; in Niederle N, von Wussow P (eds): Interferone. Berlin, Springer, 1990, pp 358-394.
22. Saastamoinen J, Syrjänen K, Syrjänen S, Mäntyjärvi R: Interferon ointment in genital warts; in Gross G, Jablonska S, Pfister H, Stegner HE (eds): Genital Papillomavirus Infections. Berlin, Springer, 1990, pp 431-432.
23. Berthold J, Schöpf E: Rezidivprophylaxe bei genitalen Warzen mit Interferon-beta-Gel; in Gross G, Bröcker EB (eds): Interferon-Therapie in der Dermatologie. München, Zuckschwerdt, 1994, pp 42-45.
24. Friedman-Kien AE, Klein RJ, Glaser RD, Czelusniak SM: Treatment of recurrent genital herpes with topical alpha Interferon gel combined with nonoxynal-9. J Am Acad Dermatol 1986;15:989-994.
25. Ophir J, Brenner S, Bali R, Kriss-Leventon S, Smetana Z, Revel M: Effect of topical interferon-β on recurrence rates in genital herpes: A double-blind, placebo-controlled, randomized study. J Int Cytokine Res 1995;15:625-631.